CompanyDeals

MSD to Migrate IT Systems to AWS, Aiming for Faster Drug Discovery and Clinical Trials

CompanyDrug

Akeso’s AK111 Achieves Key Efficacy Milestones in Phase III Trial for Plaque Psoriasis

CompanyDrug

Sichuan Kelun-Biotech to Present Promising Phase II Results for SKB264 in mTNBC at SABCS 2023

CompanyDrug

TG ImmunoPharma Secures U.S. FDA IND Approval for Promising mAb TGI-5 Targeting Multiple Cancers

CompanyDrug

Insilico Medicine Launches Clinical Study for First-in-Class PHD Inhibitor ISM5411 in IBD

CompanyDrug

Simcere Secures NMPA Approval for Edaravone Sublingual Tablets Targeting Post-Stroke Cognitive Impairment

CompanyDrug

Everest Medicines Reports Positive Phase III Results for Velsipity in Ulcerative Colitis

CompanyMedical Device

Acotec Secures FDA IDE Approval for AcoArt Litos Paclitaxel-Coated Balloon Catheter

CompanyDeals

Perpetual Medicines Launches with $8 Million Seed Round, Led by Chengwei Capital